市場調査レポート

商品コード

1544188

スマートピルの市場規模、シェア、成長分析：用途別、対象領域別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Smart Pills Market Size, Share, Growth Analysis, By Application (Capsule Endoscopy, Vital Sign Monitoring), By Target Area (Esophagus, Small Intestine), By End User (Hospitals, Diagnostic Centers), By Region - Industry Forecast 2024-2031

出版日: 2024年08月23日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

スマートピルの世界市場規模は2022年に47億米ドルと評価され、2023年の53億2,000万米ドルから2031年には139億5,000万米ドルに達し、予測期間（2024-2031年）のCAGRで12.8%の成長が予測されています。

世界のスマートピル市場は急速に進歩しており、ヘルスケアを変革する大きな可能性を秘めています。スマートピルは、デジタルピルや摂取可能なセンサーとしても知られ、飲み込むと体内からリアルタイムのモニタリングやデータ転送が可能になる小さな電子デバイスが埋め込まれたカプセルです。これらの革新的な錠剤は、診断を改善し、治療結果を最適化することにより、患者の治療を向上させるように設計されています。その目的は、医療技術と患者のモニタリングのギャップを埋めることであり、様々な健康状態を管理するための非侵襲的で便利なソリューションを提供することです。スマートピルは、服薬アドヒアランスを追跡し、バイタルサインをモニターし、異常を検出し、重要なデータをリアルタイムで医療専門家に送信することができます。いくつかの要因がスマートピル市場の成長を促進し、エキサイティングな分野となっています。心血管疾患、糖尿病、消化器疾患などの慢性疾患の増加により、継続的なモニタリングとタイムリーな介入が必要とされています。スマートピルは疾病管理と合併症の早期発見のための新しい方法を提供し、患者の転帰を改善します。さらに、高齢者人口の増加と遠隔患者モニタリングの需要が、スマートピルの採用に拍車をかけています。マイクロエレクトロニクスとワイヤレス通信の技術的進歩により、スマートピルの機能は向上しています。センサーと接続性の向上により、温度、pHレベル、薬物放出パターンなどの包括的な生理学的データ収集が可能になり、正確な診断と個別化治療が容易になった。その可能性にもかかわらず、市場はプライバシーの問題、規制のハードル、高コスト、医療専門家や患者の限られた認識といった課題に直面しています。しかし、人工知能（AI）や機械学習とスマートピルの融合といった新たな動向は、リアルタイムのデータ分析や個別化治療の機会を提供しています。製薬会社、テクノロジー企業、医療プロバイダーのコラボレーションも、イノベーションと製品開発を促進しています。こうした動きは、利害関係者にとって、医薬品開発の強化、臨床試験の最適化、医療コストの削減、患者エンゲージメントとアウトカムの改善につながる機会となります。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Medtronic PLC（Ireland）
Proteus Digital Health Inc.（US）
CapsoVision Inc.（US）
Olympus Corporation（Japan）
Medisafe（US）
Bio-Images Research Limited（UK）
BodyCap（France）
Given Imaging Ltd.（Israel）
Philips Healthcare（Netherlands）
Medimetrics Personalized Drug Delivery B.V.（Netherlands）
PENTAX Medical（Japan）
Proteus Biomedical（US）
Check-Cap Ltd.（Israel）
Smart Pill Corporation（US）
IntroMedic Co. Ltd.（South Korea）
Acamp AG（Switzerland）
Olympus Medical Systems Corporation（Japan）
Medisim Ltd.（Israel）
Medtronic Inc.（US）
Medimetrics S.A.（Belgium）

Product Code: SQMIG35I2313

Global Smart Pills Market size was valued at USD 4.7 billion in 2022 and is poised to grow from USD 5.32 billion in 2023 to USD 13.95 billion by 2031, at a CAGR of 12.8% during the forecast period (2024-2031).

The Global Smart Pills Market is rapidly advancing and holds significant potential to transform healthcare. Also known as digital pills or ingestible sensors, smart pills are capsules embedded with tiny electronic devices that, once swallowed, enable real-time monitoring and data transmission from within the body. These innovative pills are designed to enhance patient care by improving diagnosis and optimizing treatment outcomes. Their purpose is to bridge the gap between medical technology and patient monitoring, offering a non-invasive and convenient solution for managing various health conditions. Smart pills can track medication adherence, monitor vital signs, detect abnormalities, and send crucial data to healthcare professionals in real time. Several factors are driving the growth of the smart pills market, making it an exciting field. The increasing prevalence of chronic diseases like cardiovascular disorders, diabetes, and gastrointestinal conditions necessitates continuous monitoring and timely intervention. Smart pills provide a novel method for disease management and early detection of complications, improving patient outcomes. Additionally, the growing elderly population and the demand for remote patient monitoring are fueling the adoption of smart pills, which help reduce hospital visits and support independent living. Technological advancements in microelectronics and wireless communication have enhanced smart pills' capabilities. Improved sensors and connectivity allow for comprehensive physiological data collection, such as temperature, pH levels, and drug release patterns, facilitating precise diagnosis and personalized treatment. Despite their potential, the market faces challenges like privacy concerns, regulatory hurdles, high costs, and limited awareness among healthcare professionals and patients. However, emerging trends such as integrating artificial intelligence (AI) and machine learning with smart pills offer opportunities for real-time data analysis and personalized care. Collaborations between pharmaceutical companies, technology firms, and healthcare providers are also driving innovation and product development. These developments present opportunities for stakeholders to enhance drug development, optimize clinical trials, reduce healthcare costs, and improve patient engagement and outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Market Segmental Analysis

Global smart pills market is segmented on the application, target area, end-user and region. Based on application, the market is segmented into capsule endoscopy, targeted drug delivery, and vital sign monitoring. Based on target area, the market is segmented into esophagus, small intestine, large intestine, and stomach. Based on end-users, the market is segmented into hospitals, diagnostic centers, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Smart Pills Market

The increasing prevalence of gastrointestinal disorders, including Crohn's disease, irritable bowel syndrome (IBS), and colon cancer, is a key driver for the smart pills market. Smart pills equipped with advanced sensors can offer real-time insights into the digestive system, facilitating early diagnosis, personalized treatment, and enhanced patient outcomes. As gastrointestinal diseases become more widespread globally, smart pills provide a valuable tool for detecting abnormalities, monitoring disease progression, and administering targeted therapies in a non-invasive and patient-friendly way. This capability is crucial for improving the management of these conditions and addressing the growing healthcare needs associated with gastrointestinal health.

Restraints in the Global Smart Pills Market

The high cost of smart pills is a major barrier to their widespread adoption. The sophisticated technologies and manufacturing processes required to produce these pills result in higher prices compared to traditional diagnostic methods. This cost issue can restrict the accessibility of smart pills, especially in developing regions with limited healthcare resources. The expense associated with smart pills presents challenges related to affordability and reimbursement, potentially making it difficult for patients in certain areas or with constrained financial means to benefit from this advanced diagnostic technology.

Market Trends of the Global Smart Pills Market

A key trend in the smart pills market is the integration of AI algorithms and data analytics. Utilizing machine learning and advanced data analysis techniques, smart pills can deliver valuable insights, recognize patterns, and support predictive diagnostics, thereby improving the accuracy and efficiency of disease detection and monitoring. Smart pills equipped with AI capabilities can analyze real-time data from the digestive system, identify anomalies or disease markers, and offer actionable insights to healthcare providers. This integration enables early intervention and personalized treatment, enhancing overall patient care.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Technology Analysis
Supply Chain Analysis
Patent Analysis
Pricing Analysis
Consumer Analysis
Pipeline Analysis

Global Smart Pills Market By Application

Market Overview
Capsule Endoscopy
Targeted Drug Delivery
Vital Sign Monitoring

Global Smart Pills Market By Target Area

Market Overview
Esophagus
Small Intestine
Large Intestine
Stomach

Global Smart Pills Market By End-User

Market Overview
Hospitals
Diagnostic Centers
Others

Global Smart Pills Market Size By Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Digital Health Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapsoVision Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisafe (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Images Research Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BodyCap (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Given Imaging Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medimetrics Personalized Drug Delivery B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Check-Cap Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smart Pill Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IntroMedic Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acamp AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisim Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medimetrics S.A. (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

スマートピルの市場規模、シェア、成長分析：用途別、対象領域別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Smart Pills Market Size, Share, Growth Analysis, By Application (Capsule Endoscopy, Vital Sign Monitoring), By Target Area (Esophagus, Small Intestine), By End User (Hospitals, Diagnostic Centers), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

スマートピル市場：用途別

スマートピル市場：対象領域別

スマートピル市場：エンドユーザー別

スマートピル市場規模：地域別